nuroflux is a portable, digital healthcare device for continuous monitoring of brain activity, perfusion and vital signs.
There is currently no medical device available to provide objective, continuous monitoring of brain activity and blood flow, which are key indicators of stroke occurrence, treatment outcome, extent of disability and patient deterioration.
We set out to develop the world’s first wearable to non-invasively monitor brain activity and blood flow alongside other vital activity relevant to stroke and stroke rehabilitation.
Nuroflux are raising $800k at a $4.1m (AUD) pre-money valuation and would be happy to share their pitch deck with interested investors. Please reach out to the Nuroflux team for more information.